Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferric ammonium citrate is a complex salt of iron, ammonia, and citric acid, primarily utilized as a source of dietary iron and for the treatment of iron deficiency anemia. In the pharmaceutical industry, it is recognized as a well-established iron supplement, often found in multi-ingredient formulations like Geritol. Beyond its clinical application, ferric ammonium citrate (FAC) is extensively used as a research reagent to model non-transferrin-bound iron (NTBI) and iron overload. Preclinical studies have demonstrated its ability to modulate various disease pathways: it activates LRRK2 in Parkinson's disease models, downregulates Rho GTPases such as Cdc42 and RhoA to inhibit glioblastoma cell migration, and induces epithelial-mesenchymal transition (EMT) in pancreatic and ovarian cancer cells. Additionally, it is used to study the effects of iron on macrophage function in COPD and fatty acid transport at the blood-brain barrier in Alzheimer's disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferric ammonium citrate.